# LIFECORE BIOMEDICAL INC (LFCR)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/LFCR/

- Reporting holders: 3
- Reported value: $13.5K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [MassMutual Private Wealth & Trust, FSB](https://holderbook.com/funds/1103653-massmutual-private-wealth-trust-fsb/) | $12.9K | 1,966 | 0.0% | 8 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $520 | 79 | 0.0% | 9 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $20 | 3 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 3 | $13.5K |
| Q2 2026 | 102 | $138.3M |
| Q1 2026 | 106 | $93.8M |
| Q4 2025 | 104 | $203.9M |
| Q3 2025 | 100 | $179.5M |
| Q2 2025 | 88 | $199.2M |
| Q1 2025 | 88 | $190.1M |
| Q4 2024 | 78 | $202.8M |
| Q3 2024 | 83 | $117.6M |
| Q2 2024 | 77 | $120.2M |
| Q1 2024 | 80 | $124.1M |
| Q4 2023 | 79 | $137.7M |